Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community

Hepatitis Monthly

Volumn 11, Issue 4, 2011, Pages 238-239

  Miri, Seyed Mohammad ^a   Alavian, Seyed Moayed ^a  

^a Baqiyatallah Research Center for Gastroentrology and Liver Disease   (Iran)

Author keywords

Hepatitis B infection; Iran; Prevention; Risk factors; Turkey; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ARTICLE; BLOOD TRANSFUSION; HEALTH CARE POLICY; HEPATITIS B; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFECTION RISK; IRAN; MIDDLE EAST; PREVALENCE; SCREENING TEST; SEXUAL INTERCOURSE; SURGERY; TURKEY (REPUBLIC); VACCINATION; VIRUS TRANSMISSION;

EID: 84855879819     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alavian SM, Gooya MM, Hajarizadeh B, Esteghamati AR, Moeinza-deh AM, Haghazali M, et al. Mass Vaccination Campaign against Hepatitis B in Adolescents in Iran: Estimating Coverage using Administrative Data. Hepat Mon. 2009;9(3):189-95.
2. Alavian SM. Ministry of Health in Iran Is Serious about Controlling Hepatitis B. Hepat Mon. 2007;7(1):3-5.
3. Alavian SM. Hepatitis B virus infection in Iran; Changing the epidemiology. Iran J Clin Infect Dis. 2010;5(1):51-61.
4. Alavian SM, Fallahian F, Bagheri-Lankarani K. The Changing Epidemiology of Viral Hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6.
5. Alavian SM, Hajariazdeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008;8(4):281-94.
6. Azarkar Z, Sharifzadeh GHR. Efcacy of HBV Vaccination in Children with Thalassemia Major, South Khorasan, Iran. Iran Red Cres Med J. 2009;11(3):318-20.
7. Sali SH, Bashtar R, Alavian SM. Risk Factors in Chronic Hepatitis B Infection: A Case-control Study. Hepat Mon. 2005;5(4):109-15.
8. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B Prevalence and Risk Factors in Blood Donors in Ghazvin, IR Iran. Hepat Mon. 2005;5(4):117-22.
9. Ozer A, Yakupogullari Y, Beytur A, Beytur L, Koroglu M, Salman F, et al. Risk Factors for Hepatitis B Virus Infection in Turkey: A Population-Based, Case-Control Study. Hepat Mon. 2011;11(4):263-8.
10. Fallahian F, Najaf A, Alavian SM. Intravenous Drug Use: the Predominant Risk Factors for Hepatitis C Virus Infection. Shiraz E-Med J. 2010;11(4):209-18.
11. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. J Gastro-enterol Hepatol. 2002;17(10):1092-7.
12. Candan F, Alagozlu H, Poyraz O, Sumer H. Prevalence of hepatitis B and C virus infection in barbers in the Sivas region of Turkey. Occup Med (Lond). 2002;52(1):31-4.
13. Alavian SM, Zamiri N, Gooya MM, Tehrani A, Heydari ST, Lanka-rani KB. Hepatitis B vaccination of adolescents: A report on the national program in Iran. J Public Health Policy. 2010;31(4):478-93.
14. Zamani F, Fallahian F, Hashemi F, Shamsaei Z, Alavian SM. Immune response to hepatitis B vaccine in health-care workers. Saudi J Kidney Dis Transpl. 2011;22(1):179-84.
15. Alavian SM, Izadi M, Zare AA, Lankarani MM, Assari S, Vardi MM. Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists. Spec Care Dentist. 2008;28(6):265-70.